Health care startups in South San Francisco, California
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Zipline International | South San Francisco | Series I | $1.5B | 2026-11-05 |
| Moonwalk Biosciences | South San Francisco | Series B | $70.0M | 2026-09-08 |
| Xaira Therapeutics | South San Francisco | Series A | $1.0B | 2024-04-23 |
| Lycia Therapeutics | South San Francisco | Series D | $75.0M | 2026-06-25 |
| Insitro | South San Francisco | Series C | $400.0M | 2021-03-15 |
| Circle Pharma | South San Francisco | Series E | $92.5M | 2026-09-16 |
| InterVenn | South San Francisco | Series C | $201.0M | 2021-08-02 |
| ArsenalBio | South San Francisco | Series C | $325.0M | 2024-09-04 |
8 rows of the CSV in 5 of its 18 columns.
- The 67 health care startups in South San Francisco, California have raised $13.3B in total.
- 13 of them closed their most recent round in the last 12 months, $2.9B combined.
- The largest of those rounds is Zipline International's $1.5B Series I, dated November 2026.
- ARCH Venture Partners is an investor in 5 of them, more than any other fund.
- Biotech is the most common other sector, with 59 companies (88%).
- 26% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 11 to 50 employees (56% of companies with a recorded size).
- 3 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
14 of 67| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Zipline International Unicorn | Zipline designs, manufactures, and operates drones that deliver medical products. | Hardware | Series I | $1.5B | 2026-11-05 | $3.6B | Techstars, Andreessen Horowitz, Sequoia Capital +2 | 1,001 to 5,000 | 2011 |
| Circle Pharma | Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. | Biotech | Series E | $92.5M | 2026-09-16 | $300.0M | Mission BioCapital, Pfizer, The Column Group +1 | 11 to 50 | 2012 |
| Moonwalk Biosciences | Moonwalk Biosciences develops precision epigenetic medications through its genomic medicine platform. | Artificial intelligence | Series B | $70.0M | 2026-09-08 | $127.0M | Google Ventures, Khosla Ventures, ARCH Venture Partners +2 | 11 to 50 | 2022 |
| Lycia Therapeutics | Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. | Biotech | Series D | $75.0M | 2026-06-25 | $301.6M | Franklin Templeton, Alexandria Venture Investments, Invus +1 | 11 to 50 | 2019 |
| Trace Neuroscience | Trace Neuroscience aims to extend the promise of genetic medicine to patients. | Biotech | Series A | $101.0M | 2024-11-12 | $101.0M | RA Capital Management, Atlas Venture, Third Rock Ventures | 11 to 50 | 2024 |
| ArsenalBio | ArsenalBio develops programmable CAR T-cell therapies for solid tumors. | Biotech | Series C | $325.0M | 2024-09-04 | $630.8M | ARCH Venture Partners, Bristol-Myers Squibb, NVentures +1 | 251 to 500 | 2019 |
| Shinobi Therapeutics | Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment. | Biotech | Series A | $68.0M | 2024-08-06 | $178.0M | Mitsubishi UFJ Capital, F-Prime, EQT Life Sciences +2 | 11 to 50 | 2023 |
| NGM Biopharmaceuticals | NGM Biopharmaceuticals discovers and develops biotherapeutics for gastrointestinal and endocrine disorders. | Biotech | Series A | $122.0M | 2024-07-17 | $542.4M | Rho Capital Partners, Greenspring Associates, The Column Group | 11 to 50 | 2008 |
| Xaira Therapeutics Unicorn | Xaira Therapeutics applies artificial intelligence to drug discovery and biotechnology research. | Artificial intelligence | Series A | $1.0B | 2024-04-23 | $1.0B | Sequoia Capital, New Enterprise Associates, Menlo Ventures +2 | 101 to 250 | 2023 |
| HI-Bio | HI-Bio develops therapies for immune-mediated diseases. | Biotech | Series B | $95.0M | 2024-01-04 | $215.0M | ARCH Venture Partners, Alpha Wave Global, Viking Global Investors +1 | 101 to 250 | 2021 |
| Presidio Medical | Presidio Medical develops a neuromodulation platform as a medtech company. | Health care | Series C | $72.0M | 2023-06-26 | $102.0M | Deerfield, Shangbay Capital, Invus Opportunities +1 | 11 to 50 | 2017 |
| InterVenn | InterVenn uses artificial intelligence to study the glycoproteome for diagnostic and therapeutic healthcare solutions. | Artificial intelligence | Series C | $201.0M | 2021-08-02 | $244.4M | True Ventures, Boost VC, Anzu Partners +2 | 51 to 100 | 2017 |
| Insitro Unicorn | Insitro applies machine learning and biology to drug discovery and development. | Artificial intelligence | Series C | $400.0M | 2021-03-15 | $643.0M | Temasek, BlackRock, ARCH Venture Partners +1 | 251 to 500 | 2018 |
| DoctorsForMe | DoctorsForMe matches patients with complex conditions to the right medical specialists using AI. | Health care | Seed | $1.0M | 2018-03-23 | $1.0M | Emerging Technology Partners | 1 to 10 | 2018 |
Table 1. Health care startups in South San Francisco, California: the 14 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 67.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Zipline International Unicorn | Zipline designs, manufactures, and operates drones that deliver medical products. | Hardware | Series I | $1.5B | 2026-11-05 | $3.6B | Techstars, Andreessen Horowitz, Sequoia Capital +2 | 1,001 to 5,000 | 2011 |
| 2 | Circle Pharma | Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. | Biotech | Series E | $92.5M | 2026-09-16 | $300.0M | Mission BioCapital, Pfizer, The Column Group +1 | 11 to 50 | 2012 |
| 3 | Lycia Therapeutics | Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. | Biotech | Series D | $75.0M | 2026-06-25 | $301.6M | Franklin Templeton, Alexandria Venture Investments, Invus +1 | 11 to 50 | 2019 |
| 4 | Moonwalk Biosciences | Moonwalk Biosciences develops precision epigenetic medications through its genomic medicine platform. | Artificial intelligence | Series B | $70.0M | 2026-09-08 | $127.0M | Google Ventures, Khosla Ventures, ARCH Venture Partners +2 | 11 to 50 | 2022 |
Table 2. Health care startups in South San Francisco, California: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | ARCH Venture Partners | Venture capital firm | Chicago, United States | 5 | 7% | 1 | Moonwalk Biosciences |
| 2 | Sequoia Capital | Venture capital firm | Menlo Park, United States | 2 | 3% | 1 | Zipline International |
| 3 | Alpha Wave Global | Private equity firm | Miami, United States | 2 | 3% | 1 | Moonwalk Biosciences |
| 4 | F-Prime | Venture capital firm | Cambridge, United States | 2 | 3% | ||
| 5 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | 2 | 3% | 1 | Lycia Therapeutics |
| 6 | The Column Group | Venture capital firm | San Francisco, United States | 2 | 3% | 1 | Circle Pharma |
| 7 | Techstars | Startup accelerator | New York, United States | 1 | 1% | 1 | Zipline International |
| 8 | Andreessen Horowitz | Venture capital firm | Menlo Park, United States | 1 | 1% | 1 | Zipline International |
| 9 | Fidelity | Investment bank | Boston, United States | 1 | 1% | 1 | Zipline International |
| 10 | TPG | Private equity firm | San Francisco, United States | 1 | 1% | 1 | Zipline International |
| 11 | Future Ventures | Venture capital firm | San Francisco, United States | 1 | 1% | 1 | Moonwalk Biosciences |
| 12 | Google Ventures | Corporate venture arm | San Francisco, United States | 1 | 1% | 1 | Moonwalk Biosciences |
| 13 | Khosla Ventures | Venture capital firm | Menlo Park, United States | 1 | 1% | 1 | Moonwalk Biosciences |
| 14 | Menlo Ventures | Venture capital firm | Menlo Park, United States | 1 | 1% | ||
| 15 | New Enterprise Associates | Venture capital firm | Menlo Park, United States | 1 | 1% |
Table 3. Health care startups in South San Francisco, California: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
Table 4. Health care startups in South San Francisco, California by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 1 | 1% | $100K |
| Seed | 13 | 19% | $3.6M |
| Series A | 19 | 28% | $59.5M |
| Series B | 13 | 19% | $73.0M |
| Series C | 9 | 13% | $79.0M |
| Series D+ | 12 | 18% | $75.3M |
Table 5. Health care startups in South San Francisco, California by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 8% | $1.5B |
| October 2026 | 2 | 15% | $267.0M |
| September 2026 | 3 | 23% | $437.5M |
| June 2026 | 3 | 23% | $273.8M |
| March 2026 | 1 | 8% | $19.0M |
| January 2026 | 2 | 15% | $257.0M |
| December 2025 | 1 | 8% | $100.0M |
Table 6. Health care startups in South San Francisco, California: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 12 | 18% | $2.8B |
| 2025 | 8 | 12% | $562.4M |
| 2024 | 10 | 15% | $1.9B |
| 2023 | 7 | 10% | $228.7M |
| 2022 | 2 | 3% | $43.5M |
| 2021 | 7 | 10% | $824.5M |
Table 7. Health care startups in South San Francisco, California by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 6 | 9% |
| 2020 to 2022 | 11 | 17% |
| 2015 to 2019 | 28 | 42% |
| 2010 to 2014 | 8 | 12% |
| Before 2010 | 13 | 20% |
Table 8. Health care startups in South San Francisco, California by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 8 | 12% |
| 11 to 50 | 36 | 56% |
| 51 to 100 | 11 | 17% |
| 101 to 250 | 4 | 6% |
| 251 to 500 | 2 | 3% |
| 1,001 to 5,000 | 1 | 2% |
| 10,001 or more | 2 | 3% |
Table 9. Health care startups in South San Francisco, California by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in South San Francisco, California. On 16 November 2026 that is 67 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 14 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 67 rows: 7 have no round amount, 0 no city and 5 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in South San Francisco, California are on the list?
- 67, in the file dated 16 November 2026. 13 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 67 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.